NERPHARMA

NerPharMa is a drug development and manufacturing organization with a strong expertise in oncology.
NerPharMa operates as a CDMO bringing highly potent compounds, new products and unique innovative technologies to the market over the years,
delivering a wide range of GMP services through its agile and flexible facilities.
NerPharMa owns a wide and cutting edge organizational structure able to ensure the full development and production of active principles and
finished products intended for the world market as well as the research and development of innovative formulation and delivery systems.
In Nerpharma there are two divisions: NerPharMa DS (Drug Substance) and NerPharMa DP (Drug Product).
The two divisions operate in accordance with Current Good Manufacturing Practices (cGMP) and are authorized by the most relevant authorities:
Italian Drug Agency (AIFA), U.S. Food and Drug Administration (FDA), ANVISA Brazil, China FDA, PMDA Japan and Russia for the production of both pharmaceutical active ingredients and finished products.